MARKET WIRE NEWS

CURE: Analysts Strike A Cautious Tone Heading Into 2026

Source: SeekingAlpha

2025-11-26 16:28:37 ET

Introduction

Amid recent worries about the valuation of AI stocks, defensive sectors such as health care have seen an uptick in investor attention. Indeed the unlevered Health Care Select Sector SPDR Fund ETF ( XLV ) is marginally outperforming the SPDR S&P 500 ETF ( SPY ) so far in 2025, while the leveraged Direxion Daily Healthcare Bull 3X Shares ETF ( CURE ) stands out with its 32% year-to-date gain:

XLV and CURE relative to the SPY in 2025 (Seeking Alpha)

Read the full article on Seeking Alpha

For further details see:

CURE: Analysts Strike A Cautious Tone Heading Into 2026
Direxion Daily Healthcare Bull 3X Shares

NASDAQ: CURE

CURE Trading

-2.11% G/L:

$102.49 Last:

35,117 Volume:

$104.16 Open:

mwn-ir Ad 300

CURE Latest News

March 09, 2025 12:32:00 am
(CURE) Proactive Strategies

CURE Stock Data

$168,825,900
1,500,008
N/A
N/A
US

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App